IP Library › Granted Patent US 8,557,779
Granted Patent B2
US 8,557,779 · App. 12/746,257 · Granted Oct 15, 2013

Cancer vaccine composition

Inventor: Haruo Sugiyama (Minoh, JP)
Assignee: International Institute of Cancer Immunology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,779
App. No.
12/746,257
Granted
Oct 15, 2013
Kind
B2
Abstract

A cancer vaccine composition for human leukocyte antigen (HLA)-A*0206-positive persons, comprising a protein product of the tumor suppressor gene WT1 or a partial peptide thereof.

Claims (4)

1. A method of cancer treatment, comprising administering to an HLA-A*0206-positive person a composition containing a protein which is a gene product of the tumor suppressor gene WT1 or a partial peptide thereof.

2. The method of claim 1 , wherein the protein is SEQ ID NO: 1.

3. The method of claim 1 , wherein the protein is SEQ ID NO: 2, 3, 11, 16, 20, 34, 39, 46 or 49.

4. The method of claim 1 , wherein the protein is SEQ ID NO: 3.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2010
From: SUGIYAMA, HARUO
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 024517/0612 →
Priority Claims (1)
JP 2007-314552 · Dec 5, 2007 · national
Continuity (1)
Related Publication 20110070251A1 · Mar 24, 2011